Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis Ruchika Sharma10 May 2024 11:56 AM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Lifesciences aims to launch first new drug in US by early 2026 Ruchika Sharma28 Feb 2024 4:30 PM ISTAhmedabad: India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the...
Torrent Pharma, Zydus Lifescinces ink pact to co-market Saroglitazar Mg for chronic liver diseases in India Ruchika Sharma11 Nov 2023 2:15 PM ISTSaroglitazar Mg, is an innovative drug from Zydus approved by the DCGI to treat chronic liver diseases such as, Non-Alcoholic Steato Hepatitis (NASH)...
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
CDSCO Panel grants Cadila Healthcare's protocol amendment for Saroglitazar Tablets Dr. Divya Colin5 Feb 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major ....
Zydus initiates phase 2b, 3 adaptive pivotal clinical trial of Saroglitazar Mg Ruchika Sharma10 Dec 2021 4:33 PM ISTAhmedabad: Zydus, a discovery based, global pharmaceutical company today announced that it has received permission from the United States Food and...
Saroglitazar beneficial for treatment of patients with NAFLD/NASH: Study Medha Baranwal16 Oct 2021 10:15 AM ISTUSA: The administration of Saroglitazar 4 mg significantly improves liver parameters and histology and reduces the risk of cardiovascular disease in...
Zydus Cadila Saroglitazar secures USFDA Fast Track Designation to treat Primary Biliary Cholangitis Ruchika Sharma10 Dec 2020 12:27 PM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that United States Food and Drug Administration (USFDA) has granted "Fast Track...
